tested positive for covid; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (tested positive for covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for covid). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided.  Patient reported that COVID vaccines were useless. Patient received 2 shots and 2 booster shots of Moderna COVID-19 vaccine. On Thursday, patient had the 4th dose and tested positive for COVID on Sunday.  Company comment: This spontaneous case concerns a female patient (age unspecified) with no medical history reported, who experienced the unexpected non-serious AESI of Covid-19, on an unspecified date after receiving the 4th dose of mRNA-1273 vaccine. She tested positive for SARS-CoV-2 test and taken a course of Paxlovid (Nirmatrelvir + Ritonavir) for five days. The outcome was reported as unknown. Details of vaccination dates, symptoms, start date, clinical course, further investigation reports and treatment were not provided. The patient has received four doses of mRNA-1273 vaccine (dates unspecified). The current pandemic situation of Covid-19 could be a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2022: Follow up received: Added non significant information (quality complaint number).; Sender's Comments: This spontaneous case concerns a female patient (age unspecified) with no medical history reported, who experienced the unexpected non-serious AESI of Covid-19, on an unspecified date after receiving the 4th dose of mRNA-1273 vaccine. She tested positive for SARS-CoV-2 test and taken a course of Paxlovid (Nirmatrelvir + Ritonavir) for five days. The outcome was reported as unknown. Details of vaccination dates, symptoms, start date, clinical course, further investigation reports and treatment were not provided. The patient has received four doses of mRNA-1273 vaccine (dates unspecified). The current pandemic situation of Covid-19 could be a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.